Met5-enkephalin-induced cardioprotection occurs via transactivation of EGFR and activation of PI3K.
about
Prospects for Creation of Cardioprotective and Antiarrhythmic Drugs Based on Opioid Receptor AgonistsRemifentanil ameliorates intestinal ischemia-reperfusion injuryPreconditioning-mimetics bradykinin and DADLE activate PI3-kinase through divergent pathways.Glycoprotein nonmetastatic melanoma protein B extracellular fragment shows neuroprotective effects and activates the PI3K/Akt and MEK/ERK pathways via the Na+/K+-ATPase.Remote limb ischemic postconditioning protects against neonatal hypoxic-ischemic brain injury in rat pups by the opioid receptor/Akt pathway.Sex differences in the mechanism of Met5-enkephalin-induced cardioprotection: role of PI3K/Akt.The paradigm of postconditioning to protect the heart.Role and regulation of EGFR in actin remodeling in sperm capacitation and the acrosome reactionRedox balance and cardioprotection.The delta-opioid receptor agonist DADLE at reperfusion protects the heart through activation of pro-survival kinases via EGF receptor transactivation.Estradiol abolishes reduction in cell death by the opioid agonist Met5-enkephalin after oxygen glucose deprivation in isolated cardiomyocytes from both sexes.Essential role of EGFR in cardioprotection and signaling responses to A1 adenosine receptors and ischemic preconditioning.Apelin-induced cardioprotection against ischaemia/reperfusion injury: roles of epidermal growth factor and Src.The inflammatory cytokine oncostatin M induces PAI-1 in human vascular smooth muscle cells in vitro via PI 3-kinase and ERK1/2-dependent pathways
P2860
Q28066192-039EF097-75A0-48E2-A3B8-87A1FDA719A9Q34680534-24EC5452-47DF-4321-8518-A8E337309678Q35946367-5DEDA4CB-6EA1-4A5C-83E3-3376E36A10DBQ35961610-5ED370E6-7785-48A8-9EAD-897E404955BEQ36988971-E99FCDB5-0F7E-4F49-8141-454CCE92957CQ37000868-19DFAA39-035B-468C-93E4-AF4B16F9845EQ37053179-9D0639D3-2811-44D1-ABC3-278E7173C56BQ37084795-41BCE04D-D177-4775-AD75-8323144B4604Q38155452-A54CEB2C-F017-4E71-89CB-AA7481904400Q44335212-F5F9D7DA-D762-4210-8D15-8D00914B187FQ44338906-275C37BB-E0BF-4EC2-A567-2E99AE1A30A4Q44796686-6593D623-F1B4-4F1F-B3CC-26D3AE2F493BQ48022708-F1BF6F6D-EFE7-47AD-B7D4-56DCECA61F64Q58071384-8D0B331A-802F-48A4-BF5E-955873EFCDA6
P2860
Met5-enkephalin-induced cardioprotection occurs via transactivation of EGFR and activation of PI3K.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Met5-enkephalin-induced cardio ...... f EGFR and activation of PI3K.
@en
Met5-enkephalin-induced cardio ...... f EGFR and activation of PI3K.
@nl
type
label
Met5-enkephalin-induced cardio ...... f EGFR and activation of PI3K.
@en
Met5-enkephalin-induced cardio ...... f EGFR and activation of PI3K.
@nl
prefLabel
Met5-enkephalin-induced cardio ...... f EGFR and activation of PI3K.
@en
Met5-enkephalin-induced cardio ...... f EGFR and activation of PI3K.
@nl
P2093
P2860
P1476
Met5-enkephalin-induced cardio ...... f EGFR and activation of PI3K.
@en
P2093
Donna M Van Winkle
Lijuan Liu
Zhiping Cao
P2860
P304
P356
10.1152/AJPHEART.00256.2004
P577
2004-11-24T00:00:00Z